LNAI
Lunai Bioworks Inc.

3,158
Mkt Cap
$35.15M
Volume
969,869.00
52W High
$21.00
52W Low
$0.81
PE Ratio
-0.19
LNAI Fundamentals
Price
$1.48
Prev Close
$1.50
Open
$1.40
50D MA
$1.26
Beta
1.24
Avg. Volume
211,115.04
EPS (Annual)
-$10.78
P/B
-2.67
Rev/Employee
$0.00
Loading...
Loading...
Lunai Bioworks, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Los Angeles, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
29

Frequently Asked Questions

What is Market Cap of Lunai Bioworks Inc.?
What is the 52-week high for Lunai Bioworks Inc.?
What is the 52-week low for Lunai Bioworks Inc.?
What is Lunai Bioworks Inc. stock price today?
What was Lunai Bioworks Inc. stock price yesterday?
What is the PE ratio of Lunai Bioworks Inc.?
What is the Price-to-Book ratio of Lunai Bioworks Inc.?
What is the 50-day moving average of Lunai Bioworks Inc.?
How many employess does Lunai Bioworks Inc. has?

Latest LNAI News

View

Advertisement|Remove ads.

Advertisement|Remove ads.